Search results
BIOPHEN Heparin anti-IIa (Kinetics)
Assay proposed for the measurement of heparin in research applications.
BIOPHEN Heparin anti-Xa (2-stages kit)
Assay proposed for the measurement of anti-Xa heparin activity in research applications. This assay meets USP/EP requirements.
BIOPHEN Heparin LRT 3 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 7.5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Plasminogen LRT
Assay of plasminogen in human plasma for the diagnosis of congenital or acquired plasminogen deficiencies. An abnormal plasminogen activity is an indicator for fibrinolytic troubles.
BIOPHEN Protein C (LRT, Liquid Reagent Technology)
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
BIOPHEN Protein C 5
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
C1-Inhibitor, anti-human, goat, IgG, affinity purified
C1-Inhibitor, anti-human, goat, IgG, affinity purified (polyclonal)
C1-Inhibitor, anti-human, goat, IgG, purified
C1-Inhibitor, anti-human, goat, IgG, purified (polyclonal)